AstraZeneca

LuNGS Alliance launches free lung NGS biomarker testing for lung cancer patients in India

Read more

Cell and gene therapy market set to grow at 44% CAGR through 2030: GlobalData

Read more

AstraZeneca to invest $2.5 bn in new R&D centre, biotech agreements and manufacturing in Beijing

Read more

AstraZeneca to acquire EsoBiotec to advance cell therapy ambition

Read more

CDMO Live 2025 to spotlight the future of pharmaceutical outsourcing in Europe

Read more

Targeted therapies and improved diagnostics remain needs unmet in T2-low asthma

Read more

Respiratory syncytial virus prophylactic market to surpass $6 bn across 8MM in 2030

Read more

AstraZeneca invests $3.5 bn in R&D and manufacturing in the US

Read more

AstraZeneca India, Indian Academy of Paediatrics unite to raise awareness on respiratory syncytial virus in India

Read more

UCB and Biogen’s dapirolizumab pegol paves path for systemic lupus erythematosus treatment

Read more